FY 2025 NIST Small Business Innovation Research Program Phase II
ID: 358686Type: Posted
Overview

Buyer

National Institute of Standards and Technology (DOC-NIST)

Eligible Applicants

Others

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358686
Timeline
    Description

    The National Institute of Standards and Technology (NIST) is inviting applications for the FY 2025 Small Business Innovation Research (SBIR) Program Phase II, specifically targeting previous Phase I award recipients from FY 2024. This opportunity aims to support the development of market-ready products or services, with a focus on enhancing innovation in federally funded research and development, while also addressing federal R&D needs through small businesses. NIST anticipates funding approximately five awards, each up to $400,000 over a 24-month project period, with applications due by June 14, 2025, submitted via Grants.gov. For further inquiries, applicants can contact Misty Roosa at Grants@nist.gov.

    Point(s) of Contact
    Grants@nist.gov
    Files
    Title
    Posted
    2025-NIST-SBIR-02.pdf
    The FY 2025 NIST Small Business Innovation Research (SBIR) Program Phase II Notice of Funding Opportunity (NOFO) invites applications from FY 2024 Phase I award winners to develop market-ready products or services. Eligible applicants are small business concerns (SBCs) primarily employing the principal investigator at the time of award. NIST anticipates funding around five awards, each up to $400,000 over a 24-month project period, including potential Technical and Business Assistance funding. The program aims to enhance innovation in federally funded R&D, address federal R&D needs using small businesses, improve participation of socially and economically disadvantaged groups, and boost the commercialization of innovations. The application deadline is June 14, 2025, requiring submissions through Grants.gov. NIST emphasizes rigorous eligibility criteria, including performance benchmarks regarding transitioning from Phase I to Phase II, as well as commercialization rates associated with previous awards. Additionally, applicants must disclose any foreign affiliations to ensure compliance with national security measures mandated by the SBIR and STTR Extension Act of 2022. This NOFO reflects the government's broader strategy to facilitate private sector innovation and compliance with federal goals regarding research and development.
    Similar Opportunities
    NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) to support pre-clinical research aimed at bridging funding gaps that impede the commercialization of medical biotechnology products. This funding opportunity specifically targets previously funded SBIR or STTR Phase II projects, with the objective of advancing products or technologies that require federal regulatory approval, while fostering partnerships between small businesses and external investors to enhance commercialization prospects. Applicants are encouraged to secure independent third-party funding that equals or exceeds one-third of the requested NINDS funds, and must include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in the research environment. The application deadline is April 5, 2027, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found in the full announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-222.html.
    PHS 2025-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting eligible United States small business concerns (SBCs) to prepare applications for the PHS 2025-2 Omnibus Solicitation for Small Business Technology Transfer (STTR) Grant Applications, which includes Phase I, Phase II, Fast-Track, and Phase IIB grants. This opportunity aims to support innovative research and development projects that align with the NIH's mission, encouraging collaborations that leverage the technological expertise of small businesses in the health sector. The solicitation is contingent upon the reauthorization of the STTR program, with an estimated synopsis posting date of October 1, 2025, and a closing date of January 5, 2026. Interested applicants can reach out to the NIH SEED Office of Extramural Research at SEEDinfo@nih.gov or call 301-827-8595 for further information.
    NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering NINDS Renewal Awards of Small Business Innovation Research (SBIR) Phase II Grants (Phase IIB) to support clinical trials and clinical research projects focused on neurological disorders. This funding opportunity encourages small business concerns (SBCs) to seek additional funding for projects previously funded by NIH SBIR and STTR Phase II awards, with an emphasis on facilitating the transition of these projects to commercialization through partnerships with third-party investors. The initiative aims to address the "Valley of Death" funding gap in medical biotechnology, particularly for products related to the mission of the National Institute of Neurological Disorders and Stroke (NINDS). Interested applicants must submit a Commercialization Plan and a Plan for Enhancing Diverse Perspectives (PEDP), with the application opening on August 5, 2024, and a closing date of April 5, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Measurement Science and Engineering (MSE) Research Grant Programs
    National Institute of Standards and Technology
    The National Institute of Standards and Technology (NIST) has announced the Measurement Science and Engineering (MSE) Research Grant Programs for Fiscal Year 2025, inviting applications for financial assistance in various fields such as advanced manufacturing, metrology, artificial intelligence, and communications technology. This funding opportunity aims to support initiatives that enhance NIST’s partnership programs and promote U.S. innovation and industrial competitiveness, with no cost-sharing requirements for applicants. The program is open to a wide range of non-Federal entities, including educational institutions and non-profit organizations, emphasizing the importance of measurement science and standards in fostering economic security and innovation in the U.S. Applications will be accepted on a rolling basis via Grants.gov, and interested parties can contact Misty L Roosa at nofo@nist.gov for further information.
    NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)" aimed at supporting Small Business Concerns (SBCs) in conducting investigator-initiated exploratory clinical trials related to neurological disorders. This initiative encourages applications for Phase I and II studies focusing on drugs, biologics, devices, and therapies that align with the mission of the National Institute of Neurological Disorders and Stroke (NINDS), emphasizing the inclusion of a Plan for Enhancing Diverse Perspectives (PEDP) to foster innovation. The maximum funding amounts are $295,924 for Phase I and $1,972,828 for Phase II projects, with applications required to demonstrate readiness for eventual FDA regulatory approval. Interested applicants can begin submitting proposals on December 5, 2023, with the application deadline set for September 5, 2026; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NIH and CDC Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC), is offering a Small Business Innovation Research (SBIR) Grant opportunity for United States small business concerns (SBCs) to submit applications for various phases of research and development, including Phase I, Phase II, Direct to Phase II, Fast-Track, and Phase IIB grants. Eligible applicants must possess the necessary research capabilities and technological expertise to support the R&D missions of the NIH and CDC, with a focus on health-related innovations. This funding opportunity is significant as it encourages collaboration among small businesses to advance health research, with applications expected to be solicited following the reauthorization of the SBIR program. Interested parties can reach out to the NIH SEED Office at SEEDinfo@nih.gov or call 301-827-8595 for further information, with the estimated synopsis posting date set for October 1, 2025, and a closing date for applications anticipated on January 5, 2026.
    NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "NeuroNEXT Small Business Innovation in Clinical Trials," aimed at encouraging small businesses to conduct exploratory clinical trials of investigational agents related to neurological disorders. This initiative seeks applications for Phase II Small Business Innovation Research (SBIR) projects, with a budget of up to $3 million over five years, focusing on trials that align with the strategic plan of the National Institute of Neurological Disorders and Stroke (NINDS). The program is designed to foster public-private partnerships to enhance the development and commercialization of innovative therapies, ultimately improving clinical outcomes in neuroscience research. Interested applicants must adhere to a Community Engagement and Research Inclusion (CERI) plan, with the first application deadline set for January 5, 2025, and additional deadlines throughout 2026 and 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Small Business Innovation Research Program (SBIR) Phase II
    Administration for Community Living
    The Administration for Community Living is offering a grant opportunity through the Small Business Innovation Research (SBIR) Program Phase II, aimed at small businesses that have successfully completed Phase I grants between October 1, 2023, and December 31, 2025. This program seeks to stimulate technological innovation and improve the lives of people with disabilities through research and development projects that enhance health, community living, and employment outcomes. A total of four grants will be awarded, each with a funding range of $280,000 to $287,500, over a 24-month project period, with applications due by March 9, 2026. Interested applicants can reach out to Brian Bard at (202) 795-7298 or via email at brian.bard@acl.hhs.gov for further information.
    NIST MEP Competitive Awards Program
    National Institute of Standards and Technology
    The National Institute of Standards and Technology (NIST) is inviting applications for the NIST MEP Competitive Awards Program, aimed at enhancing the capabilities of the Manufacturing Extension Partnership (MEP) through innovative projects. Eligible applicants must be active MEP Centers operating under a current NIST cooperative agreement, with projects focusing on themes such as Industry 4.0, workforce development, supply chain management, and artificial intelligence. This funding opportunity, which does not require federal cost-sharing, offers up to $1 million for individual centers and up to $5 million for collaborative projects over a three-year performance period. Interested applicants can reach out to Ashley Smothers at grants@nist.gov for further information, with applications accepted on a rolling basis, subject to funding availability.
    NIGMS National and Regional Resources
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "NIGMS National and Regional Resources," aimed at supporting resources that enhance biomedical research capabilities for a large number of investigators. This program seeks to provide access to state-of-the-art technologies and expertise, enabling substantial numbers of researchers to benefit from resources that may not be available at individual institutions. The grant is open to small businesses, with no cost-sharing or matching requirements, and is categorized under discretionary funding with an estimated award date of June 1, 2026. Interested applicants can reach out to Han Nguyen, Ph.D., at han.nguyen@nih.gov or call 301-594-4640 for further information, and should note that the application period will close on September 25, 2025.